Instituto de Diagnóstico S.A.'s latest marketcap:
As of 09/26/2025, Instituto de Diagnóstico S.A.'s market capitalization has reached $419.03 M. According to our data, Instituto de Diagnóstico S.A. is the 15854th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 419.03 M |
| Revenue (ttm) | 263.63 M |
| Net Income (ttm) | 11.36 M |
| Shares Out | 140.93 M |
| EPS (ttm) | 0.08 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 05/12/2025 |
| Earnings Date | 09/05/2025 |
Instituto de Diagnóstico S.A.'s yearly market capitalization.
| Date | Market Cap(CLP) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 09/26/2025 | CLP401.65 B | $419.03 M | 81.53% | 15854 |
| 12/30/2024 | CLP221.26 B | $221.26 M | 24.3% | 18368 |
| 12/29/2023 | CLP178.01 B | $201.15 M | -21.52% | 18778 |
| 12/30/2022 | CLP226.81 B | $265.37 M | 0.59% | 16350 |
| 12/30/2021 | CLP225.49 B | $263.82 M | 7.06% | 17213 |
| 12/30/2020 | CLP210.62 B | $294.87 M | -12.6% | 14662 |
| 12/30/2019 | CLP240.99 B | $320.28 M | -22.69% | 12390 |
| 12/28/2018 | CLP311.74 B | $448.59 M | -5.63% | 9676 |
| 12/29/2017 | CLP330.33 B | $536.13 M | 13.1% | 10088 |
| 12/30/2016 | CLP292.08 B | $435.79 M | 29.56% | 9930 |
Company Profile
Instituto de Diagnóstico S.A.
Overview: Instituto de Diagnóstico S.A. is a leading provider of comprehensive health services in Chile, offering a wide range of medical solutions since its founding in 1961. Headquartered in Providencia, the company is dedicated to delivering high-quality patient care through advanced technology and specialized expertise.
Services Offered
- Patient Information & Exams: Includes indication exams and convenient online services.
- Specialty Services: Tailored medical care across various disciplines.
- Outpatient Services: Covers urgency care, laboratory testing, imaging, vaccinations, blood bank services, outpatient procedures, and reproductive medicine.
- Hospitalization Services: Features maternity care, adult and pediatric hospitalization, critical patient units, surgical procedures (including robotic surgery), and neonatology.
- Telemedicine: Provides online consultations and rehabilitation services.
- Health Centers: Specialized centers for metabolic surgery, thyroid/parathyroid care, physical rehabilitation, endometriosis, hemodynamics, and dialysis.
- Research & Training: Supports medical advancements and professional education.
- Agreements: Includes newborn, school, and accident coverage programs.
Founded: 1961
Headquarters: Providencia, Chile
Frequently Asked Questions
-
What is Instituto de Diagnóstico S.A.'s (SNSE-INDISA) current market cap?As of 09/26/2025, Instituto de Diagnóstico S.A. (including the parent company, if applicable) has an estimated market capitalization of $419.03 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Instituto de Diagnóstico S.A. (SNSE-INDISA) rank globally by market cap?Instituto de Diagnóstico S.A. global market capitalization ranking is approximately 15854 as of 09/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.